Evidence map›Paper›PMID 38115950›Full record

Trial reportInternational journal of clinical practice2023

Esketamine Combined with Propofol TCI versus Propofol TCI for Deep Sedation during Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration: A Prospective, Randomized, and Controlled Trial.

Sichen Cui, Peiying Huang, Zhanxiong Wei, Ting Guo, Aiyan Zhang, Lining Huang

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in International journal of clinical practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sichen CuiDepartment of Anesthesiology, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.ORCID https://orcid.org/0009-0005-6094-9554
Peiying HuangDepartment of Anesthesiology, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.ORCID https://orcid.org/0000-0003-2432-9903
Zhanxiong WeiDepartment of Anesthesiology, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.ORCID https://orcid.org/0009-0003-3511-7604
Ting GuoDepartment of Pneumology, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.ORCID https://orcid.org/0009-0002-4735-2655
Aiyan ZhangDepartment of Pneumology, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.ORCID https://orcid.org/0009-0001-4146-0615
Lining HuangDepartment of Anesthesiology, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.ORCID https://orcid.org/0000-0001-5754-2706
Hebei Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is an invasive procedure that required deep sedation to suppress coughing and body movements. Deep sedation, on the other hand, has been shown to cause respiratory and circulatory depression, especially when the airway is shared with the endoscopist. Esketamine is a novel sedative and analgesic with little respiratory inhibition that appears to be an appropriate adjuvant in propofol sedation for EBUS-TBNA. We compared the efficacy and safety of esketamine combined with propofol target-controlled infusion (TCI) and propofol TCI for deep sedation in EBUS-TBNA. Methods: The study included 135 patients with ASA II-III undergoing EBUS-TBNA. They were randomly divided into two groups (group E and group P). Both groups received midazolam (0.01-0.03 mg/kg) and oxycodone (0.07-0.08 mg/kg). Then, patients in group E received 0.3 mg/kg esketamine, propofol TCI, and 0.2 mg·kg Results: Patients in group E were given significantly less lidocaine (4.36 ml/h (2.67-6.00) vs 6.00 ml/h (4.36-7.20), Conclusions: In patients with ASA II-III, esketamine as an adjuvant in combination with propofol TCI deep sedation for EBUS-TBNA can improve the sedation effect, reduce coughing reaction during the procedure, and obtain more stable blood pressure. No reduction in the occurrence of sedation-related side effects was observed. This trial is registered with ChiCTR2200061124.

Indexed as

Deep SedationPropofolCoughEndoscopic Ultrasound-Guided Fine Needle AspirationHumansHypnotics and SedativesKetamineLidocaineProspective StudiesEsketamineHypnotics and SedativesKetamineLidocainePropofol

Identifiers

PMID38115950
PMCPMC10728353
OpenAlexW4389545926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.